# Astrana Health, Inc.: overview

ASTH · Nasdaq · CIK 1083446 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asth.md) · [Financials](/companies/asth/financials.md) · [Filings](/companies/asth/filings.md) · [Insiders](/companies/asth/insiders.md)

Latest reported revenue: [$972.5m](/filings/0001193125-26-342631.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-342631).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [479](/filings/0001193125-25-274359.md) | [665 d](/filings/0001193125-26-103128.md) | [620](/filings/0001193125-26-213157.md) | [655](/filings/0001193125-26-342631.md) | [956](/filings/0001193125-25-274359.md) | [951 d](/filings/0001193125-26-103128.md) | [965](/filings/0001193125-26-213157.md) | [973](/filings/0001193125-26-342631.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [5.9%](/filings/0001193125-25-274359.md) | [0.1% d](/filings/0001193125-26-103128.md) | [3.3%](/filings/0001193125-26-213157.md) | [3.1%](/filings/0001193125-26-342631.md) | [2.0%](/filings/0001193125-25-274359.md) | [1.9% d](/filings/0001193125-26-103128.md) | [3.0%](/filings/0001193125-26-213157.md) | [3.5%](/filings/0001193125-26-342631.md) |
| Net margin | % | [3.4%](/filings/0001193125-25-274359.md) | [(1.0%) d](/filings/0001193125-26-103128.md) | [1.1%](/filings/0001193125-26-213157.md) | [1.4%](/filings/0001193125-26-342631.md) | [0.0%](/filings/0001193125-25-274359.md) | [0.6% d](/filings/0001193125-26-103128.md) | [1.5%](/filings/0001193125-26-213157.md) | [2.0%](/filings/0001193125-26-342631.md) |
| Diluted EPS | $ per share | [0.33](/filings/0001193125-25-274359.md) | not reported | [0.14](/filings/0001193125-26-213157.md) | [0.19](/filings/0001193125-26-342631.md) | [0.01](/filings/0001193125-25-274359.md) | not reported | [0.29](/filings/0001193125-26-213157.md) | [0.40](/filings/0001193125-26-342631.md) |
| Free cash flow | $m | [31.7 d](/filings/0001193125-25-274359.md) | [(13.5) d](/filings/0001193125-26-103128.md) | [13.6](/filings/0001193125-26-213157.md) | [89.5 d](/filings/0001193125-26-342631.md) | [7.4 d](/filings/0001193125-25-274359.md) | [(6.0) d](/filings/0001193125-26-103128.md) | [64.1](/filings/0001193125-26-213157.md) | [28.9 d](/filings/0001193125-26-342631.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [774](/filings/0001628280-24-008024.md) | [1,144](/filings/0000950170-25-039122.md) | [1,387](/filings/0001193125-26-103128.md) | [2,035](/filings/0001193125-26-103128.md) | [3,182](/filings/0001193125-26-103128.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.7%](/filings/0001628280-24-008024.md) | [9.1%](/filings/0000950170-25-039122.md) | [6.1%](/filings/0001193125-26-103128.md) | [4.4%](/filings/0001193125-26-103128.md) | [2.5%](/filings/0001193125-26-103128.md) |
| Net margin | % | [8.9%](/filings/0001628280-24-008024.md) | [3.9%](/filings/0000950170-25-039122.md) | [4.4%](/filings/0001193125-26-103128.md) | [2.1%](/filings/0001193125-26-103128.md) | [0.7%](/filings/0001193125-26-103128.md) |
| Diluted EPS | $ per share | [1.52](/filings/0001628280-24-008024.md) | [0.99](/filings/0000950170-25-039122.md) | [1.29](/filings/0001193125-26-103128.md) | [0.90](/filings/0001193125-26-103128.md) | [0.46](/filings/0001193125-26-103128.md) |
| Free cash flow | $m | [51.1](/filings/0001628280-24-008024.md) | [59.2](/filings/0000950170-25-039122.md) | [39.7](/filings/0001193125-26-103128.md) | [44.2](/filings/0001193125-26-103128.md) | [104](/filings/0001193125-26-103128.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/asth/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $320.2m | 6,899,990 |  | Added +736,263 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $120.9m | 2,605,775 |  | Added +328,969 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $90.3m | 1,946,431 |  | Added +236,169 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $80.7m | 1,738,930 |  | Added +88,440 |
| [325 CAPITAL LLC](/funds/1873893.md) | 2026-06-30 | $74.9m | 1,613,843 |  | Reduced −225,233 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $68.1m | 1,468,508 |  | Added +100,429 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $60.0m | 1,292,573 |  | Reduced −49,251 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $54.2m | 1,167,974 |  | Added +129,889 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $39.5m | 852,145 |  | Added +277,416 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $31.8m | 685,922 |  | Added +269,797 |

## Recent filings

[All 967 filings](/companies/asth/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 08:05 ET | [8-K](/filings/0001104659-26-109822.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-109822 |
| 2026-09-23 | 07:30 ET | [8-K](/filings/0001104659-26-109813.md) | 1.05 Material cybersecurity incident | 0001104659-26-109813 |
| 2026-09-15 | 08:45 ET | [8-K](/filings/0001104659-26-107730.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-107730 |
| 2026-08-10 | 17:03 ET | [10-Q](/filings/0001193125-26-342631.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342631 |
| 2026-08-06 | 16:11 ET | [8-K](/filings/0001104659-26-092003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092003 |
| 2026-07-13 | 08:05 ET | [8-K](/filings/0001104659-26-082892.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-082892 |
| 2026-07-01 | 16:15 ET | [8-K](/filings/0001104659-26-079874.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-079874 |
| 2026-06-10 | 16:15 ET | [8-K](/filings/0001104659-26-072343.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072343 |
| 2026-05-12 | 06:06 ET | [8-K](/filings/0001104659-26-058922.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-058922 |
| 2026-05-12 | 06:03 ET | [8-K](/filings/0001104659-26-058914.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-058914 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-103128.md), filed Mar 12, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/db519221-ab70-40b2-9696-419b08e27959)

## About the filer

- CIK: 1083446
- Tickers: ASTH
- Exchange: Nasdaq
- SIC code: 8742 Services-Management Consulting Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:39 ET. No prices; not investment advice.